What are the expected lab values for a 48-year-old female, including Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and estrogen levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Expected Laboratory Values for a 48-Year-Old Female

For a 48-year-old female, expected laboratory values include an Anti-Müllerian Hormone (AMH) level of approximately 0.5-1.0 ng/ml, Follicle-Stimulating Hormone (FSH) levels that may range from normal to elevated (7-30 IU/L), and estradiol levels typically between 30-400 pg/ml, depending on menstrual cycle phase and proximity to menopause. 1

Ovarian Reserve Markers

Anti-Müllerian Hormone (AMH)

  • AMH serves as a biomarker of ovarian reserve, reflecting the quantity of remaining primordial follicles 1
  • For women approaching perimenopause (age 45-50):
    • Expected range: 0.5-1.0 ng/ml (3.6-7.1 pmol/L)
    • Values decline exponentially with age 2
    • AMH levels begin to significantly decrease after age 33 3
    • By age 48, many women show AMH levels approaching the lower detection limit of assays

Follicle-Stimulating Hormone (FSH)

  • FSH levels in a 48-year-old woman typically range from:
    • Follicular phase: 7-30 IU/L (may be elevated compared to younger women)
    • Mid-cycle: 8-30 IU/L
    • Luteal phase: 2-10 IU/L
  • FSH is inversely correlated with AMH 4
  • Rising FSH is one of the earliest hormonal signs of approaching menopause 5
  • FSH levels >10 IU/L in the early follicular phase may indicate diminished ovarian reserve

Estradiol

  • Typical ranges for a 48-year-old woman:
    • Follicular phase: 30-100 pg/ml
    • Mid-cycle peak: 100-400 pg/ml
    • Luteal phase: 50-200 pg/ml
  • Levels become more erratic during perimenopause
  • May be lower overall compared to younger women

Clinical Significance

Reproductive Potential

  • Low AMH indicates limited remaining reproductive potential 1
  • Women with low AMH (<0.7 ng/ml) have significantly higher miscarriage risk (OR 2.11; 95% CI, 1.53-2.92) 1
  • At age 48, many women are in perimenopause with declining fertility

Proximity to Menopause

  • AMH is inversely correlated with increasing age in women ≥25 years 1
  • The rate of AMH decline accelerates after age 40 2
  • By age 48, approximately 16-20% of women have AMH levels in the menopausal range 3

Antral Follicle Count (AFC)

  • AFC correlates strongly with AMH levels 4
  • Expected range for a 48-year-old woman: 2-8 follicles
  • AFC decreases with age and is a visual confirmation of declining ovarian reserve

Important Considerations

  • Laboratory values should be interpreted in the context of menstrual cycle regularity
  • Wide individual variation exists in the timing of perimenopause transition
  • AMH assays may vary between laboratories, affecting reference ranges
  • A single measurement may not fully represent a woman's reproductive status
  • FSH should be measured during the early follicular phase (days 2-4) for most accurate assessment

Common Pitfalls in Interpretation

  • Isolated hormone measurements may be misleading; trends over time are more informative
  • Oral contraceptive use can mask perimenopausal hormone changes
  • Obesity can affect hormone measurements, particularly estradiol
  • Some medical conditions (PCOS, endometriosis) may alter expected hormone patterns 6
  • AMH levels below 8 pmol/L (1.1 ng/ml) should not automatically be interpreted as approaching menopause in all women 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.